Physician profile
Benjamin Thomas Harper
NPI 1154776813
$3,488.93
in general payments reported to CMS, 2019-2025
27 companies · $690 in 2025
The $690 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.59 · 2020: $221 · 2021: $490 · 2022: $825 · 2023: $255 · 2024: $989 · 2025: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,900 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,899.76 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,007.42 | 2021-2025 | Interstim, Signia |
| Boston Scientific Corporation | $526.21 | 2020-2025 | Lithovue, Ams 700, General - Kidney Stone Disease |
| Coloplast Corp | $276.61 | 2021-2024 | |
| Cook Medical LLC | $223.50 | 2021-2023 | Fiber Dust |
| Laborie Medical Technologies Corp. | $171.68 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Teleflex LLC | $153.48 | 2022 | |
| Urogen Pharma, INC. | $140.22 | 2022-2025 | Jelmyto |
| Angiodynamics, INC. | $108.23 | 2025 | Nanoknife |
| Baxter Healthcare | $106.96 | 2021 | |
| Sumitomo Pharma America, INC. | $98.02 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $76.09 | 2024 | Xiaflex |
| Stryker Corporation | $68.00 | 2022 | |
| Astellas Pharma US INC | $67.32 | 2022 | |
| Ferring Pharmaceuticals INC. | $64.94 | 2024-2025 | Adstiladrin |
| Calyxo, INC. | $49.64 | 2025 | Cvac Aspiration System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agiliti Surgical, INC. | $45.18 | 2025 | Koelis Trinity Mri/US Fusion, Boston Scientific Lumenis Pulse 120h Holmium Laser W/ Moses Technology, Quanta System Fiber Dust Tfl Laser |
| Axonics, INC. | $43.71 | 2023-2024 | Axonics, Bulkamid |
| Olympus America INC. | $38.43 | 2023-2025 | Soltive, Itind System |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Dentsply Ih Ab | $33.69 | 2021 | |
| Abbvie INC. | $32.24 | 2022-2024 | |
| Dendreon Pharmaceuticals LLC | $27.10 | 2024 | Provenge |
| C. R. Bard, INC. & Subsidiaries | $22.43 | 2022 | |
| Myovant Sciences INC. | $20.53 | 2022 | |
| Innovation Technologies INC | $18.14 | 2023 | Irrisept |
| Covidien LP | $17.59 | 2019 | |
| Urovant Sciences INC | $16.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.